April 2011

ReferenceCell™ platform assessed by leading industry consortium
27 April 2011
NEEDHAM, Massachusetts (USA) and GRENOBLE (FRA) – April 27, 2011 – The Drug Safety Executive Council (DSEC), an industry membership run by Cambridge Healthtech Associates (CHA), together with CYTOO, a provider of innovative products for the life science research and drug discovery markets with an emphasis in cell based assays, high content analysis and cell screening, today announced a new program as part of DSEC’s Technology Evaluation Consortium. The project will assess the scientific and economic utility of the ReferenceCell™, a technology that provides quantification of cell-based...
Download info read more